Register for our free email digests:
Regulation/Legislation (Wellness)
Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
Court Tosses Amarin Fair Trade Complaint Against Omega-3 Imports
Majority opinion by Federal Circuit upheld International Trade Commission's decision and denied as moot Amarin's petition for order to compel a judicial or government officer or agency to perform a duty. Dissenting opinion not only agrees ITC acted correctly denying the firm's complaint, but also says the commission's decision wasn't appealable. Ropes & Gray attorneys suggest ruling provides guidance for additional fair trade complaints about FDA-regulated products.
Latest OTC Homeopathic Firm Using Rx Indications Also A Repeat GMP Offender
FDA says Newton Laboratories sells unapproved Rx homeopathics because its products are labeled to treat diseases and conditions including allergies, chicken pox and “suicidal tendency.” Warning letter says firm also has repeatedly violated same GMPs across more than a decade of inspections.
Regulation
Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
Latest From Wellness & Regulation
No Hiding In Social Media: More False COVID-19 Treatment Claims Found By US Agencies
FDA and FTC's latest warning letters include the first firm marketing CBD products linked with bogus COVID-19 claims. Latest warnings also mark the first the agencies submitted based completely or nearly entirely on regulatory violations found in businesses social media postings.
Supplementation During COVID-19? An Industry Perspective
Feature: Should consumers be turning to food supplements to support their immune systems during the COVID-19 epidemic? HBW Insight speaks to Professor David Richardson, scientific adviser to the Council for Responsible Nutrition UK and Nick Bennett, head of Nutrition at IVC Brunel Healthcare Ltd.
Covid-19 Scam Complaints Double In A Week, But FTC Enforcement Considers 'Good Faith' Factor
FTC pursuing bogus health and other products or services capitalizing on Covid-19 fear with scams skyrocketing. However, FTC says its enforcement will consider whether businesses are making good faith efforts to produce products in high demand.
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Article
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.